Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q3 2015 · 10-Q
Revenue$0.00$0.00— vs Q3 2014 Net Income-$1.51M-$1.51MN/M vs Q3 2014 EPS Diluted-$0.02-$0.02N/M vs Q3 2014 Operating Income-$1,512,390N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
derived
ended Sep 30, 2015 · filed Nov 9, 2015 · 40 d after period end